A new category of muscle-preserving therapies, designed specifically to be used alongside GLP-1 receptor agonists, is now generating early clinical data, and the results are prompting a broader conversation about what the next generation of obesity treatment might look like
Obesity: global epidemiology and pathogenesis
The Microdose GLP-1 Rx Program is priced at $99 to start, followed by $199 per month, which includes medication, if prescribed, and Nooms powerful GLP-1 Companion, providing clinical care, coaching, and a personalized healthy habits program
Aim for at least 1,500mg daily from all sources
Its molecular structure and sequence are optimized to support advanced laboratory studies focused on metabolic signaling, energy balance, and peptide-based innovation
Apovian, M.D., DABOM, co-director of the Center for Weight Management and Wellness at Brigham and Womens Hospital and faculty member at Harvard Medical School